- OCR remains at 3.25%; decision unanimous despite considering a 25 bp cut
- Inflation path: peak around 3% in mid-2025, declining to ~2% by early 2026
- Further cuts likely as inflation eases – August meeting will be crucial
The Reserve Bank of New Zealand (RBNZ) kept its Official Cash Rate (OCR) unchanged at 3.25%, ending a streak of six consecutive rate cuts. Policymakers judged that ample domestic spare capacity and weakening global demand will allow inflation to return to the 2% target by early 2026 — even though CPI may hover near the top of the 1–3% target band through mid-2025. Elevated export prices and prior fiscal stimulus are helping support a gradual recovery, though trade war uncertainty and rising long-term global yields weigh on the outlook.
The Monetary Policy Committee debated a 25 bp rate cut but unanimously opted to wait, citing the need for more data on economic activity, inflation, and tariffs. The tone of the statement was dovish: if medium-term inflation pressure continues to ease as projected, further easing is likely, with the next potential decision set for the August 20 Monetary Policy Statement (MPS). Nearly half of outstanding mortgages in New Zealand are due to reset at lower rates in the second half of 2025, which could loosen financial conditions even without an immediate OCR move.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appMarkets interpreted the decision as a pause before a cut, boosting expectations for rate divergence with Australia. The AUDNZD pair climbed from around 1.086 to 1.089–1.090, reaching a two-week high, as investors priced in a faster easing path from the RBNZ compared to the Reserve Bank of Australia. Diverging monetary policy paths, weak Chinese data, and renewed tariff threats from the U.S. are putting more pressure on the New Zealand dollar (NZD) than the Australian dollar (AUD).
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
